Who Paid My Doc
Azur CX Detachable
Device Vascular Embolization
PDI 00810170017483
General payments
$2,122,869
Research payments
$0
Through program year 2025, $2,122,869 in general payments and $0 in research payments were reported against Azur CX Detachable (Vascular Embolization).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $663,804 | 3,737 |
| 2024 | General | $469,563 | 3,148 |
| 2023 | General | $373,255 | 2,347 |
| 2022 | General | $397,727 | 2,237 |
| 2021 | General | $218,520 | 1,302 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 61 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
12,771 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.